市場調查報告書
商品編碼
946802

肝炎診斷檢驗市場-成長,趨勢,預測(2020年∼2025年)

Hepatitis Diagnostic Test Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

從傳統的技術大幅度轉移到分子診斷,擴大了程序的能力,縮短結果出來的時間。肝炎測試中使用的分子診斷方法包括基因測試,以確認致病病毒的確切菌株。所使用的核酸測定包括HCV RNA和HBV DNA分析測試。因此,這種先進的檢測技術的可用性刺激整個市場的成長。此外,肝炎的高流行也有望推動市場成長。

本報告提供肝炎診斷檢驗市場相關調查,市場概要,各實驗類型,各地區的趨勢,參與企業的簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 肝炎增加的負擔
    • 肝炎的診斷的分子診斷的簡介
    • 疾病相關意識的高漲
  • 市場阻礙因素
    • 肝炎檢驗的有限設施或服務
    • 可靠性高低成本的HBV及HCV診斷的獲取限制
  • 波特的五力分析

第5章 市場細分化

  • 各試驗類型
    • 血液檢驗
    • 影像檢查
    • 肝臟切片檢查
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Danaher Corporation (Beckman Coulter Inc)
    • BioMerieux SA
    • Bio-Rad Laboratories Inc
    • Diasorin SpA
    • F. Hoffmann-La Roche AG
    • Hologic Inc
    • MedMira Inc
    • Qaigen Inc
    • Siemens Healthineers

第7章 市場機會及未來趨勢

目錄
Product Code: 62299

The major shift from conventional technologies to molecular diagnostics has amplified the competence of procedures and has to pull down the dispatch time for results. Molecular diagnostics used in hepatitis testing involve genetic tests to confirm the exact strain of the causative virus. The nucleic acid assays used include HCV RNA and HBV DNA analysis tests. Hence, the availability of such advanced detection techniques is spurring the overall market growth. Furthermore, the high prevalence of hepatitis is also expected to fuel market growth. According to the U.S. Department of Health & Human Services, in 2018, most adults in their 20s and 30s made up 36.5% of newly reported chronic hepatitis C infections and this is expected to increase in the forecast period. Along with these other factors, such as increasing awareness regarding the disease may lead to the further growth of the market.

Key Market Trends

Immunoassay Segment is Expected to Show Good Growth Over the Forecast Period

Immunoassays are bioanalytical methods, in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Compared to conventional tests, immunoassays have been proven to provide highly accurate results even with very small samples. The versatile applications and ease of diagnosis have made immunoassay quite popular in recent years. Also, with the rising cases of hepatitis, the market is expected to show better growth. According to WHO, in 2019, Hepatitis B prevalence is highest in the WHO Western Pacific region and the WHO African region, where 6.2% and 6.1% of the adult population is infected respectively. Hence, owing to the aforementioned factors, along with rising technological advancements are expected to further drive the market growth.

North America is Expected to Retain Largest Market Share Over the Forecast Period

North America dominated the market with the largest revenue share. The availability of advanced diagnostic tools and high awareness regarding these products are the key factors driving the growth of the market in North America. The accelerated growth in the Canadian market can be attributed to the initiatives of the government and non-government organizations. For instance, the Public Health Agency of Canada organized the World Hepatitis Day in order to increase awareness regarding hepatitis detection. Thereby, leading to a demand surge for hepatitis detection in the country.

Competitive Landscape

The market is dominated by few global players which compete primarily on the basis of technological innovations. Key market players include Abbott Laboratories, Danaher Corporation, BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, MedMira Inc, Qaigen Inc, and Siemens Healthineers.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Hepatitis
    • 4.2.2 Introduction of Molecular Diagnostics for the Diagnosis of Hepatitis
    • 4.2.3 Increasing Awareness Regarding The Disease
  • 4.3 Market Restraints
    • 4.3.1 Limited Facilities or Services For Hepatitis Testing
    • 4.3.2 Limited Access to Reliable and Low-Cost HBV and HCV Diagnostics
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Blood Tests
      • 5.1.1.1 Liver Function Tests
      • 5.1.1.2 Immunoassays
      • 5.1.1.3 Nucleic Acid Tests
    • 5.1.2 Imaging Test
    • 5.1.3 Liver Biopsy
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Danaher Corporation (Beckman Coulter Inc)
    • 6.1.3 BioMerieux SA
    • 6.1.4 Bio-Rad Laboratories Inc
    • 6.1.5 Diasorin S.p.A
    • 6.1.6 F. Hoffmann-La Roche AG
    • 6.1.7 Hologic Inc
    • 6.1.8 MedMira Inc
    • 6.1.9 Qaigen Inc
    • 6.1.10 Siemens Healthineers

7 MARKET OPPORTUNITIES AND FUTURE TRENDS